. Author manuscript; available in PMC: 2015 Feb 23.

Published in final edited form as: J Mol Biomark Diagn. 2014 Mar 21;5:1000174. doi: 10.4172/2155-9929.1000174

Table 2.

Serum Levels of Analytes.

Predictor	Controls^† N=102	NAFLD Cases^† N=29	P-value^‡
YKL-40, log₁₀ ng/mL	1.64 (1.5-1.8)	1.55 (1.5-1.7)	0.028
Chitotriosidase, ng/mL	31 (17-48)	28 (16-47)	0.513
Glucose, mg/dL	90 (84-95)	93 (88-100)	0.042
Triglyceride, mg/dL	135 (105-207)	226 (103-441)	0.020
HDL, mg/dL	47 (41-54)	42 (35-50)	0.027
LDL, mg/dL	131 (106-157)	130 (110-157)	0.725
ALT, U/L	30 (22-39)	39 (33-54)	0.001
AST, U/L	24 (21-28)	25 (23-32)	0.069
ALP, U/L	71 (60-82)	80 (73-85)	0.012
G-GTP, U/L	24 (19-41)	29 (21-46)	0.189
Albumin, g/L	43 (41-45)	45 (42-46)	0.168

Definition of abbreviations: OR = odds ratio; 95% CI = 95% confidence interval; HDL = high-density lipoprotein; LDL = low-density lipoprotein; ALT = alanine aminotransferase; AST = aspartate transaminase; ALP = alkaline phosphatase; G-GTP = gamma-glutamyl transpeptidase

^†

Values Expressed as Median (IQR).

^‡

Significance assessed by Wilkoxon Rank Sum test